Antimicrobial Susceptibilities of Clinical Desulfovibrio Isolates

AUTOR(ES)

Lozniewski, A.

FONTE

American Society for Microbiology

RESUMO

The antimicrobial susceptibilities of 16 clinical isolates of Desulfovibrio spp. were determined. All or most isolates were susceptible to imipenem (MIC90 [MIC at which 90% of the isolates tested were inhibited], 0.5 μg/ml), metronidazole (MIC90, 0.25 μg/ml), clindamycin (MIC90, 4 μg/ml), and chloramphenicol (MIC90, 16 μg/ml) but were resistant or intermediate to penicillin G (MIC90, 64 μg/ml), piperacillin (MIC90, 256 μg/ml), piperacillin-tazobactam (MIC90, 256 μg/ml), cefoxitin (MIC90, >256 μg/ml), and cefotetan (MIC90, 64 μg/ml). Among isolates with decreased susceptibility to β-lactams (n = 15), only six were β-lactamase positive and susceptible to amoxicillin-clavulanate and ticarcillin-clavulanate.

Documentos Relacionados

• Antimicrobial Susceptibilities of Anaerobic Bacteria: Recent Clinical Isolates
• Antimicrobial susceptibilities of clinical isolates of Acinetobacter baumannii from Singapore.
• Susceptibilities of 23 Desulfovibrio Isolates from Humans▿
• Phenotypic Description and Antimicrobial Susceptibilities of Aerococcus sanguinicola Isolates from Human Clinical Samples
• In Vitro Antimicrobial Susceptibilities of Streptococcus pneumoniae Clinical Isolates Obtained in Canada in 2002